Cargando…
Xuan Fei Bai Du Fang for treating coronavirus disease 2019: A protocol for systematic review and meta-analysis
BACKGROUND: Coronavirus disease 2019 (COVID-19) is a respiratory infectious disease with a high fatality rate. Up to now, there are an estimated 26 million confirmed cases and 865,000 deaths around the world. But no effective way can control this disease. As the country that first discovered and tre...
Autores principales: | Cui, Yuying, Yao, Jinming, Shao, Guoliang, Liao, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793340/ https://www.ncbi.nlm.nih.gov/pubmed/33429731 http://dx.doi.org/10.1097/MD.0000000000023485 |
Ejemplares similares
-
The efficacy of colchicine in the management of coronavirus disease 2019: A protocol for systematic review and meta-analysis
por: Elshafei, Mohamed Nabil, et al.
Publicado: (2020) -
Coronavirus disease 2019 (COVID-19) related cytopenia: A protocol for systematic review and meta-analysis
por: Li, Yiwei, et al.
Publicado: (2020) -
Probiotics for treating novel coronavirus with diarrhea: A protocol for systematic review and meta analysis
por: Liu, Min, et al.
Publicado: (2020) -
Association between ABO blood groups and risk of coronavirus disease 2019: A protocol for systematic review and meta-analysis
por: Liu, Nanyang, et al.
Publicado: (2020) -
Risk factors for Coronavirus disease 2019 pneumonia after admission outside Wuhan, China
por: Jie, Li Shao, et al.
Publicado: (2020)